نتائج البحث 41-50 من 9868 لعملية البحث عن Hodgkin's lymphoma
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma ... The purpose of this registry is to ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. ... Hodgkin Lymphoma. Rochester, Minn., Scottsdale ...
... Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). Rochester, Minn., Jacksonville, Fla. The purpose of this study is to determine the effectiveness and ...
A Study of Prostate Cancer Care and Survivorship ... Hodgkin Lymphoma (HL) and Post-transplant ... The purpose of this study is to assess the safety and ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
... Hodgkin lymphomas. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma. Rochester, Minn ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
The purpose of this study is to evaluate the safety and ... Hodgkin Lymphoma (HL) ... This gene allows the T cells to recognize and possibly treat the cancer.
... leukemia (CLL) and non-Hodgkin's lymphoma. However, single drug therapies have limitations, therefore, the current study is evaluating a novel oral ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.